Christopher Heery

Technik-/Wissenschafts-/F&E-Leiter bei ARCELLX, INC.

Vermögen: 459 234 $ am 30.04.2024

44 Jahre

Health Technology

Consumer Services

Miscellaneous

Aktive Positionen von Christopher Heery

Unternehmen	Position	Beginn	Ende
ARCELLX, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.04.2021	-

Unternehmen	Position	Beginn	Ende
PRECISION BIOSCIENCES, INC.	Technik-/Wissenschafts-/F&E-Leiter	14.05.2019	23.04.2021
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Corporate Officer/Principal	-	-
BAVARIAN NORDIC A/S	Technik-/Wissenschafts-/F&E-Leiter	28.09.2016	-

Brody School of Medicine	Doctorate Degree
Duke University	Undergraduate Degree

International

Vereinigte Staaten	6
Dänemark	2

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
BAVARIAN NORDIC A/S	Health Technology
PRECISION BIOSCIENCES, INC.	Health Technology
ARCELLX, INC.	Health Technology

Private Unternehmen	1
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Miscellaneous

Private Unternehmen

Miscellaneous